首页> 美国卫生研究院文献>Journal of the Boston Society of Medical Sciences >De novo CD5-positive and Richters syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
【2h】

De novo CD5-positive and Richters syndrome-associated diffuse large B cell lymphomas are genotypically distinct.

机译:从头到尾CD5阳性和Richter综合征相关的弥漫性大B细胞淋巴瘤在基因型上是不同的。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Diffuse large B cell lymphomas (DLBLs) represent a heterogeneous collection of aggressive non-Hodgkin's lymphomas that can arise either de novo or as a result of transformation from chronic lymphocytic leukemia, small lymphocytic lymphoma, follicular lymphomas, or lymphomas of mucosa-associated lymphoid tissue. A small percentage of DLBLs express the CD5 antigen. The majority of these cases have evolved from a pre-existing low grade non-Hodgkin's lymphoma (Richter's syndrome). However, we identified and characterized nine CD5-positive DLBLs in which the patients did not have a previous history or concomitant evidence of chronic lymphocytic leukemia, small lymphocytic lymphoma, follicular lymphoma, or mucosa-associated lymphoid tissue-associated non-Hodgkin's lymphoma, suggesting that they arose de novo. All nine cases expressed CD20 and monotypic immunoglobulin, all eight cases examined expressed CD19, CD22 and CD43, eight of the nine cases expressed HLA-DR, and two of eight cases expressed CD11c. None of the cases expressed CD3, CD10, CD11b, CD21, CD23 or CD30. CD5 expression by these cells was found to be identical to that of CD5-positive B cell chronic lymphocytic leukemia by quantitative polymerase chain reaction analysis of CD5 mRNA. These nine de novo CD5-positive DLBLs exhibited clonal immunoglobulin heavy and light chain gene rearrangements but lacked integration of the Epstein-Barr virus genome and structural alterations of the bcl-1, bcl-2, c-myc, H-ras, K-ras, and N-ras proto-oncogenes and the p53 tumor suppressor gene. However, bcl-6 proto-oncogene rearrangement, which is involved in chromosome band 3q27 aberrations, was found in four cases (44.4%). This is comparable with the frequency of bcl-6 gene rearrangement in CD5-negative DLBL. In contrast, bcl-6 gene rearrangement was absent in six cases of DLBL associated with Richter's syndrome. These findings suggest that de novo CD5-positive DLBLs are genotypically similar to CD5-negative DLBLs and may be pathogenetically distinct from the DLBLs associated with Richter's syndrome.
机译:弥漫性大B细胞淋巴瘤(DLBL)代表了侵袭性非霍奇金淋巴瘤的异质性集合,它们可以从头发生或由于慢性淋巴细胞性白血病,小淋巴细胞性淋巴瘤,滤泡性淋巴瘤或与黏膜相关的淋巴组织淋巴瘤的转化而产生。少量的DLBLs表达CD5抗原。这些病例中的大多数是从先前存在的低度非霍奇金淋巴瘤(Richter综合征)演变而来的。但是,我们鉴定并鉴定了9例CD5阳性DLBL,其中患者没有既往病史或慢性淋巴细胞白血病,小淋巴细胞淋巴瘤,滤泡性淋巴瘤或与粘膜相关的淋巴样组织相关的非霍奇金淋巴瘤的相关证据,这表明他们从头开始。 9例均表达CD20和单型免疫球蛋白,8例均表达CD19,CD22和CD43,9例中8例表达HLA-DR,8例中2例表达CD11c。所有病例均未表达CD3,CD10,CD11b,CD21,CD23或CD30。通过CD5 mRNA的定量聚合酶链反应分析,发现这些细胞的CD5表达与CD5阳性B细胞慢性淋巴细胞性白血病的表达相同。这9个从头CD5阳性的DLBLs表现出克隆的免疫球蛋白重链和轻链基因重排,但缺乏爱泼斯坦-巴尔病毒基因组的整合以及bcl-1,bcl-2,c-myc,H-ras,K-的结构改变ras,N-ras原癌基因和p53抑癌基因。但是,有4例(44.4%)发现了bcl-6原癌基因重排,这与染色体带3q27畸变有关。这与CD5阴性DLBL中bcl-6基因重排的频率相当。相反,在六例与Richter综合征相关的DLBL病例中,bcl-6基因没有重排。这些发现表明从头CD5阳性的DLBLs在基因型上与CD5阴性的DLBLs相似,并且可能与与Richter综合征相关的DLBLs在致病性上有所不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号